Alpha Diagnostic International, Inc. Human Cachectic Factor peptide antiserum # 1 CACH11-S

Human Cachectic Factor peptide antiserum # 1 General Information Cancer cachexia is a syndrome of progressive wasting which is believed to be mediated by tumor necrosis factor-alpha, interleukins 1 and 6, and interferon-gamma, and leukemia-inhibitory factor. However, the levels of these putative agents do not correlat SugApplications Most Antibodies are tested by ELISA and Western. Additional applications, such as IHC or IP may have been tested and will be listed in the product data sheets or published research papers using our products. Typically, antibodies are tested against the SugSecAntibodies http://4adi.com/comm erce/ccc2480-seconda ry-antibodies-rabbit .htm SpeciesReactivity Human SugNegativeControl Non-immune Rabbit IgG Cat# 20009-1 Form Antiserum Unpurified SugPositiveControl Recombinant or naturally purified proteins or cells of tissues expressing the protein under study can be used as positive controls for Western or IHC. Please review the ?General Information? tan under Product overview section. Control or blocking peptid Antigen 18-aa peptide of human CF; Designated (#CACH11-P) control or blocking peptide coupled to KLH SpCrossreactivity The 18 AA human CF is unique to CF. It has some sequence homology with streptococcal preadsorbing antigen involved in pathogenesis of acute post-streptococcal glomerulonephritis (2). No significant sequence homology is detected with other proteins. Antibody cross-reactivity in various species has not been studied. For research use only, not for diagnostic or therapeutic use.